Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Smoothie King Launches GLP-1 Support Menu to Support Health and Fitness Journeys of Medication Users
-
GlycoMimetics Enters Into Acquisition Agreement With Crescent Biopharma
-
PetScreening Recognized as a Multifamily Real Estate Influencer
-
JC Bonilla Rejoins Element451 as Chief Operating Officer & Head of AI Practice
-
Neumora Therapeutics to Report Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
Presenting on the Emerging Growth Conference 76 Day 1 on October 30 Register Now
-
STANDEX ACQUIRES AMRAN INSTRUMENT TRANSFORMERS AND NARAYAN POWERTECH PVT., LTD.
-
FTV Capital Named to Inc.’s Founder-Friendly Investors List for Fourth Consecutive Year
-
Kobo Resources Reports Strong Gold Intercepts at Jagger Zone: 2.0 m at 15.99 g/t Au, 8.0 m at 3.72 g/t Au and 14.0 m at 1.53 g/t Au, Supporting Target Continuity and Expansion at Depth
-
Reejig Announces Key Senior Appointments to Accelerate U.S. Expansion and Drive Workforce Transformation
-
Builds Bio+ Announces London/UK Chapter to Boost Transatlantic Life Sciences Collaboration
-
Insulcloud Receives FDA Clearance to Expand Proprietary Diabetes Management Solution Insulclock® CAP into U.S. Market
-
STANDEX ANNOUNCES INVESTOR CALL THIS MORNING TO DISCUSS FIRST QUARTER FISCAL 2025 RESULTS AND AMRAN/NARAYAN ACQUISITION
-
Element451 Accelerates the Adoption of AI-Powered Student Engagement Solutions for California Colleges Through CollegeBuys Partnership
-
Compugen to Release Third Quarter 2024 Financial Results on Tuesday, November 12, 2024
-
Veritone to Manage and Monetize Court TV’s Expansive Digital Library
-
Will 2025 See Lower Salary Increases? Salary.com Releases Latest National Salary Budget Survey
-
Iambic Therapeutics Announces “Enchant,” an AI Platform that Predicts Clinical Outcomes from the Earliest Stages of Drug Discovery
-
ScaleReady Announces a G-Rex® Grant has been awarded to Luminary Therapeutics
-
Bitterroot Bio Completes Enrollment in Phase 1 First-in-Human Study of BRB-002 in Healthy Volunteers
-
AI Adoption Lag Leaves Asian Financial Institutions Vulnerable Amid Rising Financial Crime
-
Canadian Hospitality Operators Call for Greater Balance Between Fair Wages and Tips, According to Recent Study
-
Africa’s Fastest-Growing Fintech - Moniepoint Secures US$110 Million Investment to Scale Digital Payments and Banking Solutions
-
Remix Therapeutics Announces Participation in Jefferies London Healthcare Conference
-
Aurora Capital Partners Named to Inc.'s 2024 List of Founder-Friendly Investors
-
Treble Announces the Formation of a Hardtech Practice Group
-
Southeastern Grocers awards 50 local nonprofits with more than $480,000 in grant funds
-
Shorla Oncology Announces U.S. Food and Drug Administration (FDA) Expanded Approval of JYLAMVO™ (methotrexate), an Oncology and Autoimmune Drug for Pediatric Indications
-
EoS Fitness Celebrates a Decade of Growth and Community Impact
-
Auto Insurance Repair Cycle Times Improve but Price Increases Take a Toll, J.D. Power Finds
-
bebe stores, inc. Sells its Interests in bebe and Brookstone Brands for $46.6 million in Cash and Declares Special Dividend of $2.00 per Share
-
Today’s Workers Are Less Confident Than Actual Retirees, MFS 2024 Global Retirement Survey Finds
-
Ana Perez Joins PlanSource as Chief Marketing Officer
-
Toobit Unveils Redesigned Homepage, Elevating the User Experience for Global Crypto Traders
-
Atha Energy Announces Appointment of New Board Member and Chief Financial Officer
-
INVESTIGATION NOTICE: Girard Sharp Law Firm Encourages Iris Energy Limited (NASDAQ:IREN) Investors to Contact the Firm
-
Creative Realities Inc. Shines as a Top Workplace, Empowering Employees in Greater Louisville
-
Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)
-
Sagimet Biosciences Announces Successful Completion of End-of-Phase 2 Interactions with FDA on the Development of Denifanstat for MASH; Phase 3 Program Initiation Expected by End of 2024
-
2ONE Labs Receives PMTA 'Acceptance' for 2ONE® Nicotine Pouch brand from FDA Center for Tobacco Products
-
Amplify ETFs Launches Targeted 12% Annual Option Premium Fixed Income ETF: Amplify Bloomberg U.S. Treasury Target High Income ETF (CBOE: TLTP)
-
Bitfarms Nominates Andrew J. Chang for Election to the Board of Directors
-
Perspective Therapeutics to Participate in Upcoming Investor Conferences in November
-
Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
-
Macerich Refinances Top-Performing Queens Center at Favorable Terms
-
Coteau Grove Project, LLC Adds Bryan Perrin as Keyboardist and Vocalist
-
CodeRoad Completes Carve-Out from Mojix to Become a Leading Independent Provider of Software Development & Technology Services
-
Fractyl Health to Report Third Quarter 2024 Financial Results and Provide Business Updates on November 12, 2024
-
Crane NXT Acquires Smart Packaging Assets of TruTag Technologies, Further Expanding Capabilities in Product Security and Authentication Technologies
-
GXO Named as Top Contract Logistics Provider in Newsweek’s 2025 Ranking of America’s Most Reliable Companies
